SEC ownership of InMed Pharmaceuticals Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001728328.

Comparable stake leader

Vivo Opportunity Fund Holdings, L.P.

Disclosed value leader

Vivo Opportunity Fund Holdings, L.P.

Comparable rows

6/44

Latest evidence

16 Oct 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
6 of 44
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Vivo Opportunity Fund Holdings, L.P.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
16 Oct 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001728328
Issuer location
Vancouver

Ownership snapshot

Top shareholders of InMed Pharmaceuticals Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Vivo Opportunity Fund Hol...
Disclosed value leader
Vivo Opportunity Fund Hol...
Comparable rows
6/44
Latest evidence
16 Oct 2026
3/4/5 13D/G 13F Lead comparable stake: 22% 38 rows are not safely comparable across share classes. 13D/G row: Vivo Opportunity Fund Holdings, L.P. Showing 1-8 of 44 holder rows.

Quick read

Vivo Opportunity Fund Holdings, L.P. leads the comparable SEC ownership view at 22%.

6 of 44 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vivo Opportunity Fund Holdings, L.P.'s linked filing trail.
Comparable ownership Top 5
Vivo Opportunity Fund Holdings, L.P. 22%
ADAR1 Capital Management, LLC 17%
YA II PN, Ltd. 10%
SABBY MANAGEMENT, LLC 9.9%
Squadron Capital Management LLC 9.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 44 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Vivo Opportunity Fund Holdings, L.P.
3/4/5 13D/G
10%+ Owner
22%
Reported 13D/G · 19 May 2026
$1,268,017
818,076 shares
+$433,549 14 Jul 2026
ADAR1 Capital Management, LLC
3/4/5 13D/G 13F
10%+ Owner · Company
17%
Reported 13D/G · 30 Sep 2026
$1,262,685
956,580 shares
+$926,897 16 Oct 2026
YA II PN, Ltd.
13D/G
10%
Reported 13D/G · 13 Dec 2024
$14,885
80,372 shares
$0 13 Dec 2024
SABBY MANAGEMENT, LLC
13D/G 13F
Company
9.9%
Reported 13D/G · 31 Dec 2025
$333,364
280,138 shares
$0 31 Dec 2025
Squadron Capital Management LLC
13F 13D/G
Company · Squadron Master Fund LP
9.8%
Reported 13D/G · 19 May 2026
$503,750
325,000 shares
— 30 Jun 2026
Ikarian Capital, LLC
13F 13D/G
Company
4.2%
Reported 13D/G · 30 Jun 2026
$379,788
245,025 shares
— 30 Jun 2026
Vivo Opportunity Cayman Fund, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$1,268,017
818,076 shares
+$433,549 14 Jul 2026
Vivo Opportunity Cayman, LLC
3/4/5
10%+ Owner
—
denominator unverified
$1,268,017
818,076 shares
+$433,549 14 Jul 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$3,587,990.

Buys
$3,587,990
Insiders: 6
Sells
$0
Insiders: 0
Net
+$3,587,990
Shares: +2,355,558
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 2,355,558 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 311,160 0 $407,588 $0 +$407,588
3-6 2,044,398 0 $3,180,401 $0 +$3,180,401
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 25 reporting-owner rows connected to InMed Pharmaceuticals Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
25
Largest Forms 3/4/5 holder
Vivo Opportunity Cayman, LLC
Net 12M change
+$3,587,990
Latest report
16 Oct 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Vivo Opportunity Cayman, LLC 10%+ Owner $1,268,017 +$433,549 +52% Filing P/S 14 Jul 2026
Vivo Opportunity Cayman Fund, L.P. 10%+ Owner $1,268,017 +$433,549 +52% Filing P/S 14 Jul 2026
Vivo Opportunity Fund Holdings, L.P. 10%+ Owner $1,268,017 +$433,549 +52% Filing P/S 14 Jul 2026
Vivo Opportunity, LLC 10%+ Owner $1,268,017 +$433,549 +52% Filing P/S 14 Jul 2026
Daniel Schneeberger 10%+ Owner $1,262,685 +$926,897 +276% Filing P/S 16 Oct 2026
ADAR1 Capital Management, LLC 10%+ Owner $1,262,685 +$926,897 +276% Filing P/S 16 Oct 2026
Bruce Colwill Cfo $10,294 Mixed 24 Jan 2022
Mrs. Alexandra Diane Janet Mancini Consultant $0 Mixed 31 Jul 2024
Mr. Shane Johnson Sr VP & General Manager Mixed 19 Dec 2025
Mr. Andrew Hull Director Mixed 19 Dec 2025
Ms. Sarah Li VP Accounting & Controller Mixed 16 Dec 2022
Adam D. Cutler Director Mixed 24 Jan 2022
Nicole Lemerond Director Mixed 19 Dec 2025
Mr. Bryan Baldasare Director Mixed 20 Dec 2024
Mr. William J. Garner Director Mixed 24 Jan 2022
Mr. Neil Klompas Director Mixed 19 Dec 2025
Mr. John Bathery Director Mixed 19 Dec 2025
Mr. Jonathan Tegge Interim CFO Mixed 23 Dec 2023
Mr. Eric C. Hsu Sr. VP, Pre-Clinical Res/Dev Mixed 19 Dec 2025
Eric A. Adams President & CEO, Director Mixed 19 Dec 2025

Recent insider transactions for InMed Pharmaceuticals Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.11% $1,434 $1.32 1,086 956,580 19 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.11% $1,434 $1.32 1,086 956,580 19 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase $1.32 $1.32 1 955,494 16 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase $1.32 $1.32 1 955,494 16 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.1% $1,301 $1.32 984 955,493 15 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.1% $1,301 $1.32 984 955,493 15 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.85% $10,668 $1.33 8,021 954,509 14 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.85% $10,668 $1.33 8,021 954,509 14 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.06% $750 $1.33 564 946,488 13 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.06% $750 $1.33 564 946,488 13 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.24% $2,997 $1.33 2,256 945,924 08 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.24% $2,997 $1.33 2,256 945,924 08 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.32% $4,051 $1.33 3,046 943,668 07 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.32% $4,051 $1.33 3,046 943,668 07 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.6% $7,436 $1.33 5,601 940,622 06 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.6% $7,436 $1.33 5,601 940,622 06 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 1.98% $24,182 $1.33 18,182 935,021 05 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 1.98% $24,182 $1.33 18,182 935,021 05 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.91% $11,048 $1.33 8,307 916,839 02 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.91% $11,048 $1.33 8,307 916,839 02 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 1.84% $21,850 $1.33 16,431 908,532 01 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 1.84% $21,850 $1.33 16,431 908,532 01 Oct 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.94% $10,750 $1.29 8,340 892,101 16 Sep 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.94% $10,750 $1.29 8,340 892,101 16 Sep 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 6.54% $70,446 $1.30 54,256 883,761 15 Sep 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 6.54% $70,446 $1.30 54,256 883,761 15 Sep 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 3.56% $36,880 $1.29 28,505 829,505 14 Sep 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 3.56% $36,880 $1.29 28,505 829,505 14 Sep 2026 See Footnote
Vivo Opportunity, LLC INM Common Shares Purchase $3.1 $1.55 2 75,019 16 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase $3.1 $1.55 2 75,019 16 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase $3.1 $1.55 2 75,019 16 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase $3.1 $1.55 2 75,019 16 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase $29.45 $1.55 19 743,057 16 Jul 2026 By Vivo Opportunity Fund Holdings, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase $29.45 $1.55 19 743,057 16 Jul 2026 By Vivo Opportunity Fund Holdings, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase $29.45 $1.55 19 743,057 16 Jul 2026 By Vivo Opportunity Fund Holdings, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase $29.45 $1.55 19 743,057 16 Jul 2026 By Vivo Opportunity Fund Holdings, L.P.
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.13% $1,555 $1.56 1,000 801,000 15 Jul 2026 See Footnote
ADAR1 Capital Management, LLC INM Common Shares Purchase 0.13% $1,555 $1.56 1,000 801,000 15 Jul 2026 See Footnote
Vivo Opportunity, LLC INM Common Shares Purchase 1.89% $2,153 $1.55 1,389 75,017 15 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 1.89% $2,153 $1.55 1,389 75,017 15 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 1.89% $2,153 $1.55 1,389 75,017 15 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 1.89% $2,153 $1.55 1,389 75,017 15 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 1.89% $21,330 $1.55 13,761 743,038 15 Jul 2026 By Vivo Opportunity Fund Holdings, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 1.89% $21,330 $1.55 13,761 743,038 15 Jul 2026 By Vivo Opportunity Fund Holdings, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 1.89% $21,330 $1.55 13,761 743,038 15 Jul 2026 By Vivo Opportunity Fund Holdings, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 1.89% $21,330 $1.55 13,761 743,038 15 Jul 2026 By Vivo Opportunity Fund Holdings, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 0.67% $764 $1.55 493 73,628 14 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 0.67% $764 $1.55 493 73,628 14 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 0.67% $764 $1.55 493 73,628 14 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
Vivo Opportunity, LLC INM Common Shares Purchase 0.67% $764 $1.55 493 73,628 14 Jul 2026 By Vivo Opportunity Cayman Fund, L.P.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .